Medscape Conference Coverage, based on selected sessions at the:

2008 Joint Meeting of the American Academy of Ophthalmology (AAO) and the European Society of Ophthalmology (SOE)

November 08 - 11, 2008; Atlanta, Georgia

This activity is not sanctioned by, nor a part of, the American Academy of Ophthalmology or the European Society of Ophthalmology. Conference news does not receive grant support and is produced independently.

Conference News

  • New Dosing Strategies for Neovascular AMD

    Flexible dosing strategies and novel agents are being evaluated for the treatment of neovascular age-related macular degeneration to try to minimize the number of injections delivered while maintaining efficacy.
    Medscape Medical News, November 12, 2008
  • Eye Drops for Corneal Neovascularization

    In a small study, GS-101 eye-drop therapy resulted in a significant regression of corneal neovascularization, whereas treatment with placebo showed an increase in new vessels in all patients.
    Medscape Medical News, November 11, 2008
  • Ganciclovir Gel for Herpetic Keratitis

    Compared with patients being treated with 3% acyclovir ophthalmic ointment for herpetic keratitis, patients receiving 0.15% ganciclovir ophthalmic gel had fewer relapses and tolerated the drug better.
    Medscape Medical News, November 10, 2008
  • Ranibizumab Effective for Diabetic Macular Edema

    Results of 2 phase 2 trials suggest a benefit for ranibizumab in the treatment of diabetic macular edema.
    Medscape Medical News, November 10, 2008

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Academy of Ophthalmology or the European Society of Ophthalmology. These materials and the related activity are not sanctioned by the American Academy of Ophthalmology, the European Society of Ophthalmology, or any commercial supporters of the conference and do not constitute an official part of that conference.